Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.

about

Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.

Item

http://www.wikidata.org/entity/Q48222205

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Combination of baseline FDG PE ...... diffuse large B-cell lymphoma.

@en

Combination of baseline FDG PE ...... diffuse large B-cell lymphoma.

@nl

type

Item

label

Combination of baseline FDG PE ...... diffuse large B-cell lymphoma.

@en

Combination of baseline FDG PE ...... diffuse large B-cell lymphoma.

@nl

prefLabel

Combination of baseline FDG PE ...... diffuse large B-cell lymphoma.

@en

Combination of baseline FDG PE ...... diffuse large B-cell lymphoma.

@nl

P1476

Combination of baseline FDG PE ...... diffuse large B-cell lymphoma

@en

P2093

A Banjar

http://www.w3.org/2001/XMLSchema#string

H Tilly

http://www.w3.org/2001/XMLSchema#string

P Desbordes

http://www.w3.org/2001/XMLSchema#string

P Ruminy

http://www.w3.org/2001/XMLSchema#string

P Vera

http://www.w3.org/2001/XMLSchema#string

S Becker

http://www.w3.org/2001/XMLSchema#string

P2860

False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Stromal gene signatures in large-B-cell lymphomas

Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.

Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement

P2888

s00259-017-3907-x

P304

680-688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-017-3907-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fabrice Jardin

Isabelle Gardin

Mathieu Nessim Toledano

P577

2018-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29344718

http://www.w3.org/2001/XMLSchema#string